Antler Bio has raised $4.3M to expand its EpiHerd system, led by The First Thirty Ventures, with additional investment from Endgame Capital and Generation-RE.

Jun 26, 2025•about 1 month ago

Amount Raised

$4.3 Million

Round Type

seed

DublinFarmingBiotechnology

Investors

Generation ReEndgame CapitalThe First Thirty Ventures

Description

Dublin-based Antler Bio has raised $4.3M (nearly €3.67M) to enhance its innovative EpiHerd system. This funding round, led by The First Thirty Ventures, marks a significant step in their journey to support dairy farming through gene expression technology. With a total funding of $8.5M, they aim to promote sustainable practices in agriculture. Their EpiHerd platform is already yielding excellent results for farmers across multiple countries.

Company Information

Company

Antler Bio

Location

Dublin, Dublin, Ireland

About

Antler Bio is an agritech company focused on advancing livestock farming through gene expression technology. Founded in 2020, the company developed EpiHerd, a platform that aids dairy farmers in understanding how cows' genes respond to various factors. By providing actionable insights from complex gene data, EpiHerd supports better decision-making on farms, ultimately enhancing dairy production and animal welfare. With its innovative approach, Antler Bio aims to reshape the global food system and promote sustainable farming.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns